FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

S Ichigo

Research Profile

Chemicals & Drugs

Procedures

Polymerase Chain Reaction

Anatomy

Disorders

Phenomena

Blotting, Southern

Concepts & Ideas

Molecular Sequence Data

Physiology

Co-author Network

Publications

TOP 3
Jiro Fujimoto; Hideki Sakaguchi; R Hirose; S Ichigo; Teruhiko Tamaya
Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells.
Jiro Fujimoto; Hideki Sakaguchi; R Hirose; S Ichigo; Teruhiko Tamaya
Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers.
Jiro Fujimoto; Hideki Sakaguchi; R Hirose; S Ichigo; Teruhiko Tamaya
Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of S Ichigo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1999: Jiro Fujimoto; Hideki Sakaguchi; R Hirose; S Ichigo; Teruhiko Tamaya
Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells.
Cancer letters 1999;141(1-2):63-71.
1999: Jiro Fujimoto; Hideki Sakaguchi; R Hirose; S Ichigo; Teruhiko Tamaya
Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers.
British journal of cancer 1999;80(5-6):827-33.
1999: Jiro Fujimoto; Hideki Sakaguchi; R Hirose; S Ichigo; Teruhiko Tamaya
Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers.
British journal of cancer 1999;79(7-8):1249-54.
1998: J Fujimoto; H Sakaguchi; R Hirose; S Ichigo; T Tamaya
Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma.
Cancer 1998;83(12):2528-33.
1998: Jiro Fujimoto; S Ichigo; R Hirose; Hideki Sakaguchi; Teruhiko Tamaya
Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers.
Cancer letters 1998;134(1):15-22.
1998: Jiro Fujimoto; S Ichigo; Hideki Sakaguchi; R Hirose; Teruhiko Tamaya
Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrial cancers.
Cancer letters 1998;130(1-2):115-20.
1998: Jiro Fujimoto; S Ichigo; Hideki Sakaguchi; R Hirose; Teruhiko Tamaya
Expression of platelet-derived endothelial cell growth factor and its mRNA in uterine endometrium during the menstrual cycle.
Molecular human reproduction 1998;4(5):509-13.
1998: Jiro Fujimoto; S Ichigo; Hideki Sakaguchi; R Hirose; Teruhiko Tamaya
Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in ovarian cancers.
Cancer letters 1998;126(1):83-8.
1998: Jiro Fujimoto; R Hirose; S Ichigo; Hideki Sakaguchi; Teruhiko Tamaya
DNA polymorphism in B-domain of the estrogen receptor-alpha among Japanese women.
Steroids 1998;63(3):146-8.
1998: Jiro Fujimoto; R Hirose; S Ichigo; Hideki Sakaguchi; Y Li; Teruhiko Tamaya
Expression of progesterone receptor form A and B mRNAs in uterine leiomyoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1998;19(2):126-31.
1998: Jiro Fujimoto; S Ichigo; M Hori; Teruhiko Tamaya
Expressions of E-cadherin and alpha- and beta-catenin mRNAs in uterine endometrial cancers.
European journal of gynaecological oncology 1998;19(1):78-81.
1998: Jiro Fujimoto; M Hori; S Ichigo; S Morishita; Teruhiko Tamaya
Estrogen and progestin inhibit invasiveness of gynecologic metastatic cancer cells to blood vessel endothelium.
European journal of gynaecological oncology 1998;19(1):42-5.
1997: Jiro Fujimoto; S Ichigo; R Hirose; Hideki Sakaguchi; Teruhiko Tamaya
Clinical implication of expression of progesterone receptor form A and B mRNAs in secondary spreading of gynecologic cancers.
The Journal of steroid biochemistry and molecular biology 1997;62(5-6):449-54.
1997: Jiro Fujimoto; S Ichigo; R Hirose; Hideki Sakaguchi; Teruhiko Tamaya
Expression of E-cadherin and alpha- and beta-catenin mRNAs in ovarian cancers.
Cancer letters 1997;115(2):207-12.
1997: Jiro Fujimoto; M Hori; S Ichigo; R Hirose; Hideki Sakaguchi; Teruhiko Tamaya
Plausible novel therapeutic strategy of uterine endometrial cancer with reduction of basic fibroblast growth factor secretion by progestin and O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470).
Cancer letters 1997;113(1-2):187-94.
1997: Jiro Fujimoto; S Ichigo; R Hirose; Hideki Sakaguchi; Teruhiko Tamaya
Expression of estrogen receptor wild type and exon 5 splicing variant mRNAs in normal and endometriotic endometria during the menstrual cycle.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1997;11(1):11-6.
1997: J Fujimoto; M Hori; S Ichigo; R Hirose; T Tamaya
Antiestrogenic compounds inhibit estrogen-induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells.
General pharmacology 1997;28(2):215-9.
1997: Jiro Fujimoto; M Hori; S Ichigo; Teruhiko Tamaya
Antiestrogenic compounds inhibit estrogen-induced expression of fibroblast growth factor family (FGF-1, 2, and 4) mRNA in well-differentiated endometrial cancer cells.
European journal of gynaecological oncology 1997;18(6):497-501.
1997: Jiro Fujimoto; S Ichigo; R Hirose; Hideki Sakaguchi; Teruhiko Tamaya
Suppression of E-cadherin and alpha- and beta-catenin mRNA expression in the metastatic lesions of gynecological cancers.
European journal of gynaecological oncology 1997;18(6):484-7.
1997: Ryou Misao; Y Nakanishi; Jiro Fujimoto; S Ichigo; Teruhiko Tamaya
Expression of sex hormone-binding globulin and corticosteroid-binding globulin mRNAs in corpus luteum of human subjects.
Hormone research 1997;48(4):191-5.
1997: Jiro Fujimoto; S Ichigo; M Hori; R Hirose; Hideki Sakaguchi; Teruhiko Tamaya
Expression of basic fibroblast growth factor and its mRNA in advanced ovarian cancers.
European journal of gynaecological oncology 1997;18(5):349-52.
1997: Jiro Fujimoto; S Ichigo; R Hirose; Hideki Sakaguchi; Teruhiko Tamaya
Expression of E-cadherin and alpha- and beta-catenin mRNAs in uterine cervical cancers.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(4):206-12.
1997: Jiro Fujimoto; S Ichigo; R Hirose; M Hori; Teruhiko Tamaya
Expression of estrogen receptor exon 5 splicing variant (ER E5SV) mRNA in gynaecological cancers.
The Journal of steroid biochemistry and molecular biology 1997;60(1-2):25-30.
1997: Jiro Fujimoto; M Hori; S Ichigo; Teruhiko Tamaya
Ovarian steroids regulate the expression of basic fibroblast growth factor and its mRNA in fibroblasts derived from uterine endometrium.
Annals of clinical biochemistry 1997;34 ( Pt 1)():91-6.
1997: Jiro Fujimoto; S Ichigo; M Hori; R Hirose; Hideki Sakaguchi; Teruhiko Tamaya
Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers.
Cancer letters 1997;111(1-2):21-6.
1997: Jiro Fujimoto; M Hori; S Ichigo; R Hirose; Hideki Sakaguchi; Teruhiko Tamaya
Comparative study on expression of plasminogen activator inhibitor 1 and its mRNA in endometrial cancers and normal endometria.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(1):13-21.
1997: Ryou Misao; Y Nakanishi; Jiro Fujimoto; M Hori; S Ichigo; Teruhiko Tamaya
Expression of sex hormone-binding globulin mRNA in uterine cervical cancers.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(1):6-12.
1996: Jiro Fujimoto; M Hori; S Ichigo; Teruhiko Tamaya
Sex steroids regulate the expression of plasminogen activator inhibitor-1 and its mRNA in fibroblasts derived from uterine endometrium.
Annals of clinical biochemistry 1996;33 ( Pt 6)():545-50.
1996: Jiro Fujimoto; M Hori; S Ichigo; Teruhiko Tamaya
Sex steroids regulate the expression of plasminogen activator inhibitor-1 (PAI-1) and its mRNA in uterine endometrial cancer cell line Ishikawa.
The Journal of steroid biochemistry and molecular biology 1996;59(1):1-8.
1996: Jiro Fujimoto; S Ichigo; M Hori; Teruhiko Tamaya
Expression of E-cadherin, alpha- and beta-catenin mRNAs in ovarian endometriosis.
European journal of obstetrics, gynecology, and reproductive biology 1996;67(2):179-83.
1996: Jiro Fujimoto; M Hori; S Ichigo; Teruhiko Tamaya
Expression of basic fibroblast growth factor and its mRNA in uterine endometrium during the menstrual cycle.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1996;10(3):193-7.
1996: Jiro Fujimoto; S Ichigo; M Hori; Teruhiko Tamaya
Alteration of E-cadherin, alpha- and beta-catenin mRNA expression in human uterine endometrium during the menstrual cycle.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1996;10(3):187-91.
1996: Jiro Fujimoto; M Hori; S Ichigo; S Morishita; Teruhiko Tamaya
Estrogen induces expression of c-fos and c-jun via activation of protein kinase C in an endometrial cancer cell line and fibroblasts derived from human uterine endometrium.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1996;10(2):109-18.
1996: Jiro Fujimoto; S Ichigo; M Hori; S Morishita; Teruhiko Tamaya
Progestins and danazol effect on cell-to-cell adhesion, and E-cadherin and alpha- and beta-catenin mRNA expressions.
The Journal of steroid biochemistry and molecular biology 1996;57(5-6):275-82.
1996: Jiro Fujimoto; M Hori; S Ichigo; S Morishita; Teruhiko Tamaya
Novel screening technique for dissemination potential of ovarian cancer cells to peritoneum.
Invasion & metastasis 1996;16(6):302-7.
1996: Jiro Fujimoto; M Hori; S Ichigo; Teruhiko Tamaya
Expressions of the fibroblast growth factor family (FGF-1, -2 and -4) mRNA in endometrial cancers.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1996;17(4):226-33.
1996: Jiro Fujimoto; M Hori; S Ichigo; S Morishita; Teruhiko Tamaya
Estrogen activates migration potential of endometrial cancer cells through basement membrane.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1996;17(1):48-57.
1995: S Morishita; Kenji Niwa; S Ichigo; M Hori; T Murase; Jiro Fujimoto; Teruhiko Tamaya
Overexpressions of c-fos/jun mRNA and their oncoproteins (Fos/Jun) in the mouse uterus treated with three natural estrogens.
Cancer letters 1995;97(2):225-31.
1995: Ryou Misao; Y Nakanishi; Jiro Fujimoto; S Ichigo; M Hori; Teruhiko Tamaya
Expression of corticosteroid-binding globulin mRNA in human uterine endometrial cancers.
Steroids 1995;60(10):720-4.
1995: Jiro Fujimoto; S Ichigo; M Hori; S Morishita; Teruhiko Tamaya
Estrogen induces c-Ha-ras expression via activation of tyrosine kinase in uterine endometrial fibroblasts and cancer cells.
The Journal of steroid biochemistry and molecular biology 1995;55(1):25-33.
1995: Jiro Fujimoto; S Ichigo; M Hori; S Morishita; Teruhiko Tamaya
Oestrogen induces c-Ha-ras expression in the fibroblasts derived from human uterine endometrium.
Annals of clinical biochemistry 1995;32 ( Pt 5)():487-92.
1995: Ryou Misao; Y Nakanishi; Jiro Fujimoto; M Hori; S Ichigo; Teruhiko Tamaya
Expression of sex hormone-binding globulin mRNA in human ovarian cancers.
European journal of endocrinology / European Federation of Endocrine Societies 1995;133(3):327-34.
1995: Jiro Fujimoto; M Hori; S Ichigo; T Itoh; Masanao Saio; T Takami; Teruhiko Tamaya
Induction of M-CSF receptor and its mRNA, and activation of tyrosine kinase in peripheral monocytes by oestradiol-17 beta and progesterone.
Annals of clinical biochemistry 1995;32 ( Pt 4)():399-404.
1995: Ryou Misao; Y Nakanishi; S Ichigo; M Hori; Jiro Fujimoto; Teruhiko Tamaya
Expression of sex hormone-binding globulin mRNA in human endometrial cancers.
The Journal of steroid biochemistry and molecular biology 1995;52(6):517-22.
1995: Jiro Fujimoto; M Nishigaki; M Hori; S Ichigo; T Itoh; Teruhiko Tamaya
Biological implications of estrogen and androgen effects on androgen receptor and its mRNA levels in human uterine endometrium.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1995;9(2):149-55.
1995: Jiro Fujimoto; M Hori; T Itoh; S Ichigo; M Nishigaki; Teruhiko Tamaya
Danazol decreases transcription of estrogen receptor gene in human monocytes.
General pharmacology 1995;26(3):507-16.
1995: Ryou Misao; M Nishigaki; M Hori; S Ichigo; Jiro Fujimoto; Teruhiko Tamaya
Effects of danazol and medroxyprogesterone acetate on estrogen-(estradiol and estriol) specific binding sites in rabbit uterus.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1995;9(1):29-35.
1995: Jiro Fujimoto; M Ilori; S Ichigo; S Morishita; Teruhiko Tamaya
Estrogen induces the expression of c-fos and c-jun genes in fibroblasts derived from human uterine endometrium.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1995;103(6):378-85.
1995: Jiro Fujimoto; M Hori; S Ichigo; Teruhiko Tamaya
Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers.
Invasion & metastasis 1995;15(5-6):203-10.
1995: Jiro Fujimoto; M Hori; S Ichigo; S Morishita; Teruhiko Tamaya
Estrogen activates invasiveness of endometrial cancel cells to the interstitium.
Invasion & metastasis 1995;15(3-4):135-43.
1995: Jiro Fujimoto; M Hori; S Ichigo; Ryou Misao; Teruhiko Tamaya
Preliminary study of oncogene expressions in endometrial cancers. Aberrant estrogen receptor gene and erbB-2 expressions.
European journal of gynaecological oncology 1995;16(1):40-7.
1995: Ryou Misao; M Hori; S Ichigo; Jiro Fujimoto; Teruhiko Tamaya
Levels of sex hormone-binding globulin (SHBG) and corticosteroid-binding globulin (CBG) messenger ribonucleic acid (mRNAs) in ovarian endometriosis.
Reproduction, nutrition, development 1995;35(2):155-65.
1995: Jiro Fujimoto; M Hori; S Ichigo; S Morishita; Teruhiko Tamaya
Clinical implication of fos and jun expressions and protein kinase activity in endometrial cancers.
European journal of gynaecological oncology 1995;16(2):138-46.
1995: Jiro Fujimoto; S Ichigo; M Hori; M Nishigaki; Teruhiko Tamaya
Expression of progesterone receptor form A and B mRNAs in gynecologic malignant tumors.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1995;16(4):254-60.
1994: Ryou Misao; M Hori; S Ichigo; Jiro Fujimoto; Teruhiko Tamaya
Corticosteroid-binding globulin mRNA levels in human uterine endometrium.
Steroids 1994;59(10):603-7.
1994: Jiro Fujimoto; M Nishigaki; M Hori; S Ichigo; T Itoh; Teruhiko Tamaya
The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects.
The Journal of steroid biochemistry and molecular biology 1994;50(3-4):137-43.
1994: Jiro Fujimoto; M Hori; S Ichigo; M Nishigaki; Teruhiko Tamaya
Tissue differences in the expression of mRNAs of Ha-ras, c-myc, fos and jun in human uterine endometrium, myometrium and leiomyoma under the influence of estrogen/progesterone.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1994;15(6):311-7.
1994: Jiro Fujimoto; M Hori; S Ichigo; M Nishigaki; T Itoh; Teruhiko Tamaya
Expression of aberrant estrogen receptor mRNA in endometrial cancers in comparison with normal endometria.
Hormone research 1994;42(3):116-9.